Rx Reimbursement Model Must Change For Pharma To Flourish, Castellani Says

The pharmaceutical industry must work to change two "insidious" reimbursement paradigms if it hopes to be able to continue to develop additional medications, PhRMA CEO John Castellani said in his first major policy address.